Exclusive

Publication

Byline

Location

US Patent Issued to Endeavor BioMedicines on April 21 for "Methods of treating fibrosis" (California Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,377, issued on April 21, was assigned to Endeavor BioMedicines Inc. (San Diego). "Methods of treating fibrosis" was invented by Luis A Del... Read More


US Patent Issued on April 21 for "Small therapeutic molecules capable of inhibiting the catalytic activity of the main protease enzyme of SARS-CoV-2" (Turkish Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,378, issued on April 21. "Small therapeutic molecules capable of inhibiting the catalytic activity of the main protease enzyme of SARS-CoV... Read More


US Patent Issued to Endeavor BioMedicines on April 21 for "Methods of improving lung function" (California Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,379, issued on April 21, was assigned to Endeavor BioMedicines Inc. (San Diego). "Methods of improving lung function" was invented by Migu... Read More


US Patent Issued to Endeavor BioMedicines on April 21 for "Methods of improving lung function" (California Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,380, issued on April 21, was assigned to Endeavor BioMedicines Inc. (San Diego). "Methods of improving lung function" was invented by Migu... Read More


US Patent Issued to BEIJING TIDE PHARMACEUTICAL on April 21 for "Method for treating endometriosis-associated pain by using diaminopyrimidine compound" (Chinese Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,381, issued on April 21, was assigned to BEIJING TIDE PHARMACEUTICAL Co. LTD. (Beijing). "Method for treating endometriosis-associated pai... Read More


US Patent Issued to JBKLAB on April 21 for "Pharmaceutical composition for preventing, alleviating, or treating cancer containing 2,6-dichloro-4-(4-(4-hydroxycyclohexylamino)-7H- pyrrolo[2,3-dpyrimidin-5-yl)phenol as active ingredient" (South Korean Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,382, issued on April 21, was assigned to JBKLAB Co. Ltd. (Seongnam-si, South Korea). "Pharmaceutical composition for preventing, alleviati... Read More


US Patent Issued to UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION on April 21 for "Methods of treating cancer" (Chinese, American Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,383, issued on April 21, was assigned to UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (Pittsburgh). "Methods of... Read More


US Patent Issued to INTRA-CELLULAR THERAPIES on April 21 for "Uses" (New York, California, New Jersey Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,384, issued on April 21, was assigned to INTRA-CELLULAR THERAPIES INC. (Bedminster, N.J.). "Uses" was invented by David Kass (New York), T... Read More


US Patent Issued to SHORLA PHARMA on April 21 for "Methotrexate formulation" (British Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,385, issued on April 21, was assigned to SHORLA PHARMA LTD (Co. Tipperary, Ireland). "Methotrexate formulation" was invented by Michael Fr... Read More


US Patent Issued to APR Applied Pharma Research on April 21 for "Sapropterin formulation" (British Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,386, issued on April 21, was assigned to APR Applied Pharma Research SA (Balerna, Switzerland). "Sapropterin formulation" was invented by ... Read More